Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Light

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Comprehensive Therapy|June 1, 1986
Orthostatic hypotension: clinical spectrum and approach to treatmentM V Tantengco, J Onrot, D Robertson, et al.
The American Journal of the Medical Sciences|July 1, 1988
Neuropeptide Y is a vasoconstrictor of human coronary arteriesC J Tseng, D Robertson, R T Light, et al.
Circulation|March 1, 1989
Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activationA K Bajaj, M A Cobb, R Virmani, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansC Funck-Brentano, R T Light, M D Lineberry, et al.
Circulation|August 1, 1987
Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusionM B Forman, D W Puett, S E Bingham, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Comprehensive Therapy|June 1, 1986
Orthostatic hypotension: clinical spectrum and approach to treatmentM V Tantengco, J Onrot, D Robertson, et al.
The American Journal of the Medical Sciences|July 1, 1988
Neuropeptide Y is a vasoconstrictor of human coronary arteriesC J Tseng, D Robertson, R T Light, et al.
Circulation|March 1, 1989
Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activationA K Bajaj, M A Cobb, R Virmani, et al.
Journal of Cardiovascular Pharmacology|September 1, 1989
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humansC Funck-Brentano, R T Light, M D Lineberry, et al.
Circulation|August 1, 1987
Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusionM B Forman, D W Puett, S E Bingham, et al.
Pageof 2